Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2001
Relating radiation-induced regional lung injury to changes in pulmonary function tests
M Fan, L B Marks, P Lind, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2001
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer
M L Hernando, L B Marks, G C Bentel, et al.
Genes, Chromosomes & Cancer
|
December 29, 1999
Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor
T D Shafman, S Levitz, A J Nixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2001
Relating radiation-induced regional lung injury to changes in pulmonary function tests
M Fan, L B Marks, P Lind, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2001
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer
M L Hernando, L B Marks, G C Bentel, et al.
Genes, Chromosomes & Cancer
|
December 29, 1999
Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor
T D Shafman, S Levitz, A J Nixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2000
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
I Cokgor, G Akabani, C T Kuan, et al.
Page
of 2